Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2024 of $0.21 per Class A ...

On Oct. 6, The Wall Street Journal reported that activist investor group Starboard Value owns a stake in Pfizer ( PFE -2.82%) ...

Mizuho Securities analyst Salim Syed has maintained their bullish stance on BBIO stock, giving a Buy rating on October 9. Salim Syed’s ...

Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff ...

The treatment of metabolic dysfunction-associated steatohepatitis (MASH) has proven challenging, with many compounds failing during development for various reasons. However, with the recent ...

Gritstone Bio announced it is “taking action” to “preserve value and strengthen capital structure” on Thursday.

GSK shares rose after the British drug major agreed to pay up to $2.2 billion to settle thousands of U.S. lawsuits over claims its discontinued heartburn medicine Zantac caused cancer. Write to Rob ...

As the battle over Pfizer’s future continues, former executives said they would no longer support activist investor Starboard ...

Hedge fund Starboard Value's activist campaign targeting Pfizer (PFE) divides Wall Street, with analysts questioning the ...

On Sunday, The Guardian issued an article that spoke of a UK study that could transform how cancer is treated. The ...

Activist investor Starboard Value claims the pharma giant’s former CEO and CFO were “threatened” into backing current ...